Work

Phase 2a Randomized Controlled Trial of TPN ‐101, A Nucleoside Reverse Transcriptase Inhibitor, in Progressive Supranuclear Palsy

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Movement Disorders

DOI: 10.1002/mds.70470

Authors: Andrew Satlin, Michael G. Cordingley, Debra K. Liebert, Walter Bee, Ethan G. Geier, John M. Sedivy, Jay Soto, Jianmin Duan, Samuel P. Dickson, Leslie Chu, Eckard Weber

Institutions: Transposon Therapeutics, Inc. (United States), Brown University

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7203884064

FWCI:

Cites: 29

Cited by:

Related to: